Fortis Advisors, LLC Eli Lilly & CO Transaction History

Fortis Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	BUY	$221.6 - $272.71 $14.1 Million - $17.3 Million	63,539 New	63,539 $64,000
Q2 2020 Aug 13, 2020	SELL	$136.42 - $164.18 $85,126 - $102,448	-624 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$106.79 - $116.16 $34,386 - $37,403	322 Added 106.62%	624 $70,000
Q1 2019 May 15, 2019	BUY	$111.31 - $131.02 $33,615 - $39,568	302 New	302 $39,000

4,011

751M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Fortis Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Fortis Advisors, LLC with notifications on news.